Status:
RECRUITING
The Effectiveness of Written Exposure Therapy for PTSD
Lead Sponsor:
Peking University
Conditions:
PTSD
Subclinical PTSD
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Study 1: The goal of this study is to use a pilot RCT to assess the effectiveness of Written Exposure Therapy (WET) and a mindfulness-based app (MBA) for managing PTSD and comorbid insomnia in China. ...
Eligibility Criteria
Inclusion
- Study 1:
- Adult male and female aged between 18-65 years old; A diagnosis of PTSD or subthreshold PTSD (PTSD Symptom Scale, Interview Version for DSM-5, PSSI-5); If currently taking psychotropic medication, taking a stable one for at least 4 weeks; A smartphone owner and no obstacle to the Now Meditation App; Scoring 12 or more on Insomnia Severity Index (ISI; the symptoms appear after the diagnosis of full/subthreshold PTSD).
Exclusion
- A diagnosis of bipolar disorder or psychotic disorder; Current substance dependence; Evidence of a moderate or severe traumatic brain injury (as determined by the obstacle to comprehending the baseline screening questionnaires); Serious suicidal ideation (as determined by the Scale for Suicidal Ideation); Other psychiatric disorders severe enough to warrant designation as the primary disorder; Taking psychotherapy for PTSD currently.
- Study 2:
- Inclusion Criteria:
- Adult male and female (aged between 18-65 years old)
- A diagnosis of PTSD or subclinical PTSD (PTSD Symptom Scale, Interview Version for DSM-5, PSSI-5), meeting the following criteria: Meeting full criteria for re-experiencing and at least 2 of 3 other symptom clusters (i.e., avoidance, negative cognitions, or hyperarousal)
- If currently taking psychotropic medication, taking a stable one for at least 4 weeks
- Having the ability to write and comprehend the writing guidelines
Key Trial Info
Start Date :
June 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2024
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT05421494
Start Date
June 15 2022
End Date
December 10 2024
Last Update
October 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University
Beijing, Beijing Municipality, China, 100871